The long-acting MC4R agonist Setmelanotide has demonstrated profound and durable weight loss in patient with monogenic defects along this axis, [] thus validating the leptin-melanocortin pathway as a highly druggable target for precision obesity medicine
Effects on cognition and global function were evaluated with the Alzheimers Disease Assessment Scale Cognitive Subscale (ADAS-Cog) and the Clinician Interview-Based Impression of Change with Caregiver Input scale (CIBIC+) at 4, 12, and 24 weeks after the start of injections
Samples were vortexed again, centrifuged (16,000 g , 10 min, 4 C) and then all supernatant was removed to leave a protein pellet
Analyzed the data: SL QL LL
That being said, the high doses of the nootropic measured at 0.5 mg/kg/day for intraperitoneal delivery and 2.0 mg/kg/day for oral delivery, and resulted in a performance that was indistinguishable from the control group and significantly better than the animals treated with scopolamine alone [2]